Parametric Portfolio Associates’s Kiniksa Pharmaceuticals KNSA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | $1.14M | Sell |
114,766
-34,989
| -23% | -$348K | ﹤0.01% | 2721 |
|
|
2021
Q4 | $1.76M | Buy |
149,755
+79,609
| +113% | +$937K | ﹤0.01% | 2509 |
|
|
2021
Q3 | $799K | Buy |
70,146
+4,558
| +7% | +$51.9K | ﹤0.01% | 2898 |
|
|
2021
Q2 | $914K | Sell |
65,588
-6,555
| -9% | -$91.3K | ﹤0.01% | 2809 |
|
|
2021
Q1 | $1.34M | Buy |
72,143
+4,974
| +7% | +$92K | ﹤0.01% | 3025 |
|
|
2020
Q4 | $1.19M | Buy |
67,169
+30,913
| +85% | +$546K | ﹤0.01% | 2957 |
|
|
2020
Q3 | $555K | Buy |
36,256
+3,222
| +10% | +$49.3K | ﹤0.01% | 3222 |
|
|
2020
Q2 | $842K | Sell |
33,034
-7,498
| -18% | -$191K | ﹤0.01% | 3008 |
|
|
2020
Q1 | $627K | Sell |
40,532
-18,325
| -31% | -$283K | ﹤0.01% | 3041 |
|
|
2019
Q4 | $651K | Buy |
58,857
+7,285
| +14% | +$80.6K | ﹤0.01% | 3270 |
|
|
2019
Q3 | $439K | Buy |
51,572
+19,977
| +63% | +$170K | ﹤0.01% | 3390 |
|
|
2019
Q2 | $428K | Buy |
31,595
+4,787
| +18% | +$64.8K | ﹤0.01% | 3423 |
|
|
2019
Q1 | $484K | Buy |
26,808
+4,243
| +19% | +$76.6K | ﹤0.01% | 3353 |
|
|
2018
Q4 | $634K | Sell |
22,565
-1,357
| -6% | -$38.1K | ﹤0.01% | 3209 |
|
|
2018
Q3 | $610K | Buy |
23,922
+7,218
| +43% | +$184K | ﹤0.01% | 3334 |
|
|
2018
Q2 | $290K | Buy |
+16,704
| New | +$290K | ﹤0.01% | 3565 |
|